Search

Author/Creator Ellison, Misoo C

1. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence. (10th March 2018)

Authors:
Gerding, Dale N; Kelly, Ciaran P; Rahav, Galia; Lee, Christine; Dubberke, Erik R; Kumar, Princy N; Yacyshyn, Bruce; Kao, Dina; Eves, Karen; Ellison, Misoo C; Hanson, Mary E; Guris, Dalya; Dorr, Mary Beth
Journal:
Clinical infectious diseases
Issue:
Volume 67:Number 5(2018)
Page Start:
649
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Influence of Diagnostic Method on Outcomes in Phase 3 Clinical Trials of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: A Post Hoc Analysis of MODIFY I/II. (3rd August 2019)

Authors:
Wilcox, Mark H; Rahav, Galia; Dubberke, Erik R; Gabryelski, Lori; Davies, Kerrie; Berry, Claire; Eves, Karen; Ellison, Misoo C; Guris, Dalya; Dorr, Mary Beth
Journal:
Open forum infectious diseases
Issue:
Volume 6:Number 8(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040. (14th May 2020)

Authors:
Harrington, Kevin J; Soulières, Denis; Le Tourneau, Christophe; Dinis, Jose; Licitra, Lisa F; Ahn, Myung-Ju; Soria, Ainara; Machiels, Jean-Pascal H; Mach, Nicolas; Mehra, Ranee; Burtness, Barbara; Ellison, Misoo C; Cheng, Jonathan D; Chirovsky, Diana Romana; Swaby, Ramona F; Cohen, Ezra E W
Journal:
Journal of the National Cancer Institute
Issue:
Volume 113:Number 2(2021)
Page Start:
171
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗